{"id":5936,"date":"2019-09-11T16:40:36","date_gmt":"2019-09-11T11:10:36","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=5936"},"modified":"2023-08-17T10:55:46","modified_gmt":"2023-08-17T05:25:46","slug":"regenerative-medicine-in-japan","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/regenerative-medicine-in-japan","title":{"rendered":"Japan is transforming its Healthcare sector through Regenerative Medicine"},"content":{"rendered":"\n<p class=\"has-drop-cap\">Regenerative medicine is an innovative approach to regrow and repair the damaged cells, tissues or organs. The process involves the regeneration of the lost body cells by stimulating the body\u2019s own immune system. <br>Regenerative medicine includes a group of biomedically engineered approaches that uses therapeutic stem cells, tissue engineering and the production of artificial organs. Cell therapies, immunomodulation therapy, and tissue engineering are all the landmark achievements in the Healthcare domain. <\/p>\n\n\n\n<p>Regenerative medicine enables\nresearchers and scientists to artificially grow tissues and organs and execute\ntheir safe implantation into the patient. <\/p>\n\n\n\n<p>Current estimates indicate that\napproximately one in three Americans could potentially benefit from\nregenerative medicine.<\/p>\n\n\n\n<p><strong>Japan\u2019s Healthcare Reforms <\/strong><\/p>\n\n\n\n<p>Recognized as the World\u2019s third-largest economy, <a href=\"https:\/\/www.delveinsight.com\/events\/bio-japan-2019\">Japan spent around \u00a542.2 trillion on Healthcare<\/a> in the year 2017, as calculated by the Ministry of Health, Labor, and Welfare.<\/p>\n\n\n\n<p>Japan\u2019s Healthcare reforms are proceeding to perfect the accountability and support from the healthcare system for egalitarian, economical and efficient medical services to Japanese population. <\/p>\n\n\n\n<p>The year 2014 marked the journey of regenerative medicine in Japan\u2019s healthcare domain. Reforms and amendments in two of the major pharmaceutical laws namely Pharmaceuticals and Medical Devices Act and Act on the Safety of Regenerative Medicine defined regenerative medical products, pharmaceuticals and medical devices. <\/p>\n\n\n\n<p>Moreover, Japan offers a\nuniversal insurance system which allows enrollees to take up the insurance plan\nas per their requirements. <\/p>\n\n\n\n<p><strong>How Regenerative medicine fuelled Japan\u2019s Healthcare sector? <\/strong><\/p>\n\n\n\n<p>Tissue engineering and\nregenerative medicine are hailed as major breakthroughs. So far, 90 clinical\ntrials have been approved from the year 2014 when it first began.<\/p>\n\n\n\n<p>Regenerative medicine market is expanding rapidly in Japan and in the world. Japan spent around USD 90 Million in the year 2012 which is expected to reach USD 25 Billion by the year 2050. This hike in the healthcare expenditure is mainly attributed to the reforms made to promote the commercialization and market authorization of regenerative medicines in Japan. <\/p>\n\n\n\n<p><strong>Regenerative medicine approved therapies<\/strong><\/p>\n\n\n\n<p>Regenerative medicine market has in total of three approved products for the treatment of different diseases. TEMCELL HS Inj. A product by JCR Pharmaceuticals for treating Graft-versus-host disease, HeartSheet developed by Terumo Corporation for patients suffering from Heart failure caused by ischemic heart disease and JACE a drug candidate of Japan Tissue Engineering approved for treating Giant congenital melanocytic nevus.<\/p>\n\n\n\n<p><strong>What could be the challenges in Regenerative medicine market? <\/strong><\/p>\n\n\n\n<p>Along with increasing life\u2013expectancy, regenerative medicines have the potential to provide the complete cure of chronic diseases. However, the success rate lies in only a few numbers of diseases. Complex diseases like diabetes would require stricter and thorough research. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Regenerative medicine is an innovative approach to regrow and repair the damaged cells, tissues or organs. The process involves the regeneration of the lost body cells by stimulating the body\u2019s own immune system. Regenerative medicine includes a group of biomedically engineered approaches that uses therapeutic stem cells, tissue engineering and the production of artificial organs. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5937,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[812,6601,17776,675,2904,712],"industry":[17225],"therapeutic_areas":[17235],"class_list":["post-5936","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-diabetes","tag-graft-versus-host-disease-4","tag-gvhd","tag-healthcare","tag-japan","tag-pharma-industry","industry-pharmaceutical","therapeutic_areas-cell-and-gene-therapy"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Japan is transforming its Healthcare sector through Regenerative Medicine -<\/title>\n<meta name=\"description\" content=\"Regenerative medicine market is expanding rapidly in Japan and in the world. Japan spent around USD 90 Million in the year 2012 which is expected to...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/regenerative-medicine-in-japan\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Japan is transforming its Healthcare sector through Regenerative Medicine -\" \/>\n<meta property=\"og:description\" content=\"Regenerative medicine market is expanding rapidly in Japan and in the world. Japan spent around USD 90 Million in the year 2012 which is expected to...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/regenerative-medicine-in-japan\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-11T11:10:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-17T05:25:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/09\/17140409\/regenerative-medicine.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"772\" \/>\n\t<meta property=\"og:image:height\" content=\"482\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Japan is transforming its Healthcare sector through Regenerative Medicine -","description":"Regenerative medicine market is expanding rapidly in Japan and in the world. Japan spent around USD 90 Million in the year 2012 which is expected to...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/regenerative-medicine-in-japan","og_locale":"en_US","og_type":"article","og_title":"Japan is transforming its Healthcare sector through Regenerative Medicine -","og_description":"Regenerative medicine market is expanding rapidly in Japan and in the world. Japan spent around USD 90 Million in the year 2012 which is expected to...","og_url":"https:\/\/www.delveinsight.com\/blog\/regenerative-medicine-in-japan","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2019-09-11T11:10:36+00:00","article_modified_time":"2023-08-17T05:25:46+00:00","og_image":[{"width":772,"height":482,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/09\/17140409\/regenerative-medicine.jpg","type":"image\/jpeg"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/regenerative-medicine-in-japan","url":"https:\/\/www.delveinsight.com\/blog\/regenerative-medicine-in-japan","name":"Japan is transforming its Healthcare sector through Regenerative Medicine -","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/regenerative-medicine-in-japan#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/regenerative-medicine-in-japan#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/09\/17140409\/regenerative-medicine.jpg","datePublished":"2019-09-11T11:10:36+00:00","dateModified":"2023-08-17T05:25:46+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"Regenerative medicine market is expanding rapidly in Japan and in the world. Japan spent around USD 90 Million in the year 2012 which is expected to...","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/regenerative-medicine-in-japan"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/regenerative-medicine-in-japan#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/09\/17140409\/regenerative-medicine.jpg","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/09\/17140409\/regenerative-medicine.jpg","width":772,"height":482,"caption":"Japan's regenerative medicine"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/09\/17140409\/regenerative-medicine-300x187.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Diabetes<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Graft versus host disease<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">GVHD<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Healthcare<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Japan<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Pharma Industry<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Diabetes<\/span>","<span class=\"advgb-post-tax-term\">Graft versus host disease<\/span>","<span class=\"advgb-post-tax-term\">GVHD<\/span>","<span class=\"advgb-post-tax-term\">Healthcare<\/span>","<span class=\"advgb-post-tax-term\">Japan<\/span>","<span class=\"advgb-post-tax-term\">Pharma Industry<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 7 years ago","modified":"Updated 3 years ago"},"absolute_dates":{"created":"Posted on Sep 11, 2019","modified":"Updated on Aug 17, 2023"},"absolute_dates_time":{"created":"Posted on Sep 11, 2019 4:40 pm","modified":"Updated on Aug 17, 2023 10:55 am"},"featured_img_caption":"Japan's regenerative medicine","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/5936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=5936"}],"version-history":[{"count":0,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/5936\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/5937"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=5936"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=5936"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=5936"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=5936"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=5936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}